Critical Path Institute (C-Path)
Luke Kosinski is the Scientific Director of Quantitative Medicine at Critical Path Institute (C-Path) since August 2020. Prior to this role, Luke worked as a Quantitative Medicine Scientist and Postdoctoral Researcher at C-Path. Before joining C-Path, Luke was a Graduate Research Assistant at the University of Arizona from August 2014 to August 2020. Luke holds a Ph.D. in Cell/Cellular and Molecular Biology from the University of Arizona, a Master's degree in Evolutionary Biology from Midwestern University (AZ), a Master's degree in Philosophy from Louisiana State University, and a Bachelor's degree in English Language and Literature from Arizona State University.
Critical Path Institute (C-Path)
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and dozens of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona and C-Path, Ltd. EU is headquartered in Dublin, Ireland, with additional staff in multiple other locations. For more information, visit c-path.org and c-path.eu.